Entreprises CDMO de remplissage de cartouches|
Services de fabrication de cartouches injectables

Vos partenaires de confiance pour la fabrication et le développement de cartouches injectables

Applied Filters:Injectables×Cartouches×FDF / DRUG PRODUCTS×Clear All

Showing 22 facilities

Sort by:

Chine

Sichuan Huiyu Pharmaceuticals Co., Ltd. - R&D Site

Seacross Pharmaceutical Co Ltd

Le centre de R&D joue un rôle fondamental en soutenant le développement d’API et de formes posologiques finies.

Discover our facility

Markets: ISP (Chile), MSPAS (Guatemala), FDA (USA), COFEPRIS (Mexico), DIGEMID (Peru), EMA (EU), PMDA (Japan), NMPA (China), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), Russian Health Authorities, SFDA (Saudi Arabia), ANMAT (Argentina), CDSCO (India), MFDS (South Korea), INVIMA (Colombia), Turkish Health Authorities, EDE (UAE), TGA (Australia), Reste du monde

Batch Size: Large, Small, Medium

Compliance: FDA (cGMP), DIGEMID, BRCGS, ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, Roszdravnadzor (Russia GMP), IFS, Halal Research Council, INVIMA, TGA (Australia GMP), TITCK (Turkish Health Authorities), ECOVADIS, ISP (Chile BPM), French Service-Public (CIR), Health Canada (Canada GMP), MHRA (UK GMP), ANMAT (Argentina nueva GMP), World Health Organization (GMP / HACCP), EMA (EU GMP), NMPA (China GMP), MFDS/KFDA (Republic of Korea GMP), NSF, SQF (Safe Quality Food), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority)

Services: Development services, Logistics, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging

Use: Human

BSL (Biological Safety Level): 1, 2, 3, 4

Therapeutic Areas of Expertise (ATC): (V04) Diagnostic agents, (N) Nervous system, (S) Sensory organs, (V09-10) Radiopharmaceuticals, (B) Blood and blood forming organs, (D) Dermatologicals, (J) Antiinfectives for systemic use, (V06) Nutrients, (V01) Allergens, (R) Respiratory system, (P) Antiparasitic products, insecticides and repellents, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (H) Systemic hormonal preparations excl. sex hormones and insulins, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism

Controlled Substances: Lowest potential for abuse, Lower potential for abuse, High potential for abuse & no medical use, Low potential for abuse, High potential for abuse & medical use

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Category / Product: FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC

Region: APAC

Chine

Sichuan Huiyu Pharmaceuticals Co., Ltd. - Formulation Manufacturing Site

Seacross Pharmaceutical Co Ltd

Le site de fabrication de formulations est dédié au développement et à la production de formes galéniques complexes et de grande valeur.

Discover our facility

Markets: Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), FDA (USA), EMA (EU), PMDA (Japan), NMPA (China), DIGEMID (Peru), MHRA (UK), Russian Health Authorities, CDSCO (India), Turkish Health Authorities, EDE (UAE), SFDA (Saudi Arabia), ANMAT (Argentina), INVIMA (Colombia), MFDS (South Korea), TGA (Australia), Reste du monde

Batch Size: Large, Small, Medium

Use: Human

BSL (Biological Safety Level): 1, 2, 3, 4

Compliance: ISO, FDA (cGMP), DIGEMID, BRCGS, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, Roszdravnadzor (Russia GMP), IFS, Halal Research Council, TGA (Australia GMP), TITCK (Turkish Health Authorities), INVIMA, ECOVADIS, ISP (Chile BPM), French Service-Public (CIR), World Health Organization (GMP / HACCP), NMPA (China GMP), Health Canada (Canada GMP), MHRA (UK GMP), ANMAT (Argentina nueva GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP), NSF, SQF (Safe Quality Food), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority)

Services: Development services, Logistics, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging

Therapeutic Areas of Expertise (ATC): (V04) Diagnostic agents, (B) Blood and blood forming organs, (D) Dermatologicals, (J) Antiinfectives for systemic use, (N) Nervous system, (S) Sensory organs, (V06) Nutrients, (V01) Allergens, (R) Respiratory system, (P) Antiparasitic products, insecticides and repellents, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (H) Systemic hormonal preparations excl. sex hormones and insulins, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism

Controlled Substances: Lowest potential for abuse, Lower potential for abuse, High potential for abuse & no medical use, Low potential for abuse, High potential for abuse & medical use

Category / Product: FDF / DRUG PRODUCTS, CRO ANALYTIQUE

Region: APAC

Italie

Aenova Group - Location Latina, Italy

Aenova

Centre de compétences produits de santé animale et technologies stériles.

Discover our facility

Markets: ANVISA (Brazil), FDA (USA), EMA (EU), Russian Health Authorities, Turkish Health Authorities, SFDA (Saudi Arabia)

Batch Size: Large, Small, Medium

Use: Human, Veterinary

BSL (Biological Safety Level): 1, 2

Compliance: FDA (cGMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TITCK (Turkish Health Authorities), EMA (EU GMP), SFDA (Saudi Food & Drug Authority)

Services: Development services, Logistics, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Category / Product: FDF / DRUG PRODUCTS

Region: Europe

Turquie

GENSENTA ILAC SANAYI AS

GENSENTA

FABRICANT CMO & CDMO & FDF

Discover our facility

Batch Size: Large, Small, Medium

Use: Human

Markets: FDA (USA), EMA (EU), PMDA (Japan), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), Russian Health Authorities, MFDS (South Korea), Turkish Health Authorities, SFDA (Saudi Arabia), TGA (Australia)

Services: Development services, Analytical / QC services, Packaging, Manufacturing services, Quality Assurance services

Compliance: ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), PMDA/MHLW (Japan GMP), TITCK (Turkish Health Authorities), TGA (Australia GMP), Health Canada (Canada GMP), MHRA (UK GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP), SFDA (Saudi Food & Drug Authority)

Controlled Substances: Lowest potential for abuse, Lower potential for abuse, Low potential for abuse, High potential for abuse & medical use

Therapeutic Areas of Expertise (ATC): (D) Dermatologicals, (J) Antiinfectives for systemic use, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (M) Musculoskeletal system, (C) Cardiovascular system, (A) Digestive tract and metabolism

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Category / Product: FDF / DRUG PRODUCTS, CRO ANALYTIQUE

Region: Europe

États-Unis

Lifecore Injectables CDMO

Lifecore Biomedical

CDMO qui fabrique des produits pharmaceutiques injectables stériles cliniques et commerciaux.

Discover our facility

Batch Size: Large, Small, Medium

Use: Human, Veterinary

BSL (Biological Safety Level): 1, 2, 3

Compliance: ISO, FDA (cGMP), ANVISA (Brazil B-GMP), TGA (Australia GMP), ECOVADIS, EMA (EU GMP), Health Canada (Canada GMP), MFDS/KFDA (Republic of Korea GMP)

Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), Russian Health Authorities, CDSCO (India), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), SFDA (Saudi Arabia), ANMAT (Argentina), INVIMA (Colombia), TGA (Australia), Reste du monde

Services: Development services, Logistics, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging

Controlled Substances: Lowest potential for abuse

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Category / Product: FDF / DRUG PRODUCTS

Region: North America

Allemagne

EVER Pharma Jena GmbH

EVER Neuro Pharma GmbH

CDMO spécialisé dans le développement et la production de petites molécules injectables.

Discover our facility

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day)

Controlled Substances: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

Markets: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India), TGA (Australia), Reste du monde

Services: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

Region: Europe

Compliance: ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TITCK (Turkish Health Authorities), NMPA (China GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)

Batch Size: Large, Small, Medium

Use: Human

BSL (Biological Safety Level): 1, 2

Therapeutic Areas of Expertise (ATC): (H) Systemic hormonal preparations excl. sex hormones and insulins, (L) Antineoplastic and immunomodulating agents, (N) Nervous system

Category / Product: FDF / DRUG PRODUCTS

Belgique

Cenexi Laboratoires Thissen

Cenexi

Cette usine de 8.000 m2, répartie sur un terrain de près de sept hectares, est située à 20 km au sud de Bruxelles et compte 340 salariés*.

Discover our facility

BSL (Biological Safety Level): 3, 4, 1, 2

Controlled Substances: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

Markets: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), TGA (Australia)

Region: Europe

Compliance: FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), TGA (Australia GMP), NMPA (China GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

Batch Size: Large, Small, Medium

Use: Human, Veterinary

Services: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

Therapeutic Areas of Expertise (ATC): (H) Systemic hormonal preparations excl. sex hormones and insulins, (L) Antineoplastic and immunomodulating agents, (G) Genito urinary system and sex hormones

Category / Product: FDF / DRUG PRODUCTS

Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

Finition de remplissage stérile en phase précoce

Location available after registration

Inscription gratuite Contact MAI to connect

Limited view

COSMETICS manufacturing site

MAI network supplier

Solutions CDMO à guichet unique pour les APL et les intermédiaires clés.

Location available after registration

Inscription gratuite Contact MAI to connect

Limited view

FDF / DRUG PRODUCTS manufacturing site

MAI network supplier

Développement et fabrication de produits pharmaceutiques sous forme de poudres et de liquides secs et stériles à dose orale solide (OSD), nasale, pour inhalatio

Location available after registration

Inscription gratuite Contact MAI to connect

HIPRA BIOTECH SERVICES | Amer

HIPRA Biotech Services

Capacités internes de bout en bout, du développement de lignées cellulaires à la fabrication commerciale.

Discover our facility

Services: Development services, Logistics, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services

Markets: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)

Compliance: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

BSL (Biological Safety Level): 1, 2

Use: Human, Veterinary

Batch Size: Large, Small, Medium

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Category / Product: FDF / DRUG PRODUCTS, BIOLOGICS

Region: Europe

Slovaquie

HBM Pharma

Hbm Pharma

OGM certifiée EU-GMP basée à Martin, Slovaquie. L'entreprise fournit des services de fabrication et d'emballage de produits pharmaceutiques stériles. produits et formes posologiques orales solides

Discover our facility

Markets: EMA (EU), NMPA (China), Health Canada (Canada), ANVISA (Brazil), COFEPRIS (Mexico), Russian Health Authorities, MHRA (UK), SFDA (Saudi Arabia), Turkish Health Authorities, TGA (Australia)

Compliance: ISO, Roszdravnadzor (Russia GMP), ECOVADIS, TGA (Australia GMP), UAE Ministry of Health & Prevention, NMPA (China GMP), EMA (EU GMP), Health Canada (Canada GMP), ANVISA (Brazil)

Use: Human

Batch Size: Large, Small, Medium

Services: Analytical / QC services, Packaging, Quality Assurance services, Manufacturing services

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Controlled Substances: High potential for abuse & medical use

Category / Product: FDF / DRUG PRODUCTS, CRO ANALYTIQUE

Region: Europe

More facilities on the network

+12 more facilities

Create free account

Cartridges are a key format for injectable drug delivery — especially in combination products like insulin pens, autoinjectors, and multi-dose delivery systems. Their precision, user convenience, and compatibility with self-administration devices make them ideal for chronic therapies. To meet strict quality and regulatory standards, pharma and biotech innovators rely on specialized cartouche remplissant les sociétés CDMO.

Avec service completfabrication de cartouches injectables, ces CDMO offrent une prise en charge de la formulation, du remplissage aseptique, de l'intégration des dispositifs et du conditionnement dans des conditions BPF mondiales.

Comment choisir les sociétés CDMO de remplissage de cartouches

Lors de la sélection parmicartouche remplissant les sociétés CDMOIl doit prendre en compte des facteurs importants tels que:

Capacités de remplissage-finition stériledans les environnements ISO 5 (RABS/isolateurs)
Device compatibilityavec 1,5 ml, 3 ml et des cartouches personnalisées
Manipulation de produits biologiques sensibles ou à haute viscosité
Prise en charge des formats à double chambre et lyophilisés
Chaîne du froid et infrastructure à haut confinementEn cas de besoin
Antécédents avec des produits combinéset le soutien réglementaire pour les dépôts DMF, NDA et CE
Étiquetage, sérialisation et emballage intégrés

Un CDMO qualifié s'assure que votre produit de cartouche répond aux objectifs cliniques, techniques et commerciaux.

Principaux services offerts par les partenaires de fabrication de cartouches injectables

Fournisseurs de premier plan defabrication de cartouches injectablesLes services comprennent généralement :

Formulation developmentadapté aux systèmes de cartouches
remplissage aseptiquede cartouches de verre ou de polymère
Insertion de la butée, assemblage du piston et sertissage
Étiquetage, inspection visuelle et sérialisation
Container Closure Integrity Testing (CCIT)
Lyophilisation et remplissage à double chambreLe cas échéant
Stability studiesen vertu des directives de l'ICH
Regulatory supportpour les dépôts de combinaisons de produits et de médicaments

Ces services sont essentiels pour les thérapies du diabète, du remplacement hormonal, de l'ophtalmologie et des maladies rares.

Advantages of Partnering with Cartridge Filling CDMO Companies

Travailler avec un expertcartouche remplissant les sociétés CDMOoffre plusieurs avantages :

Sortie prête pour l'appareilpour les auto-injecteurs, les stylos et les systèmes réutilisables
Diminution du Time to marketavec flux de travail de remplissage-finition intégrés
Amélioration de l'observance du patientvia des formats pratiques
Regulatory alignmentavec une expérience produit combinée
Qualité homogènedans le remplissage aseptique et l'assemblage du dispositif

Un CDMO performant vous aide à rationaliser votre programme d'injection, de la formulation à l'intégration finale du dispositif.

Sociétés CDMO de remplissage de cartouches

Some of the most trusted cartouche remplissant les sociétés CDMOment par :

EVER Neuro Pharma GmbH : Specialized CDMO for the development and production of small-molecule injectables. [Voir le profil CDMO]
GENSENTA :Fabricant CMO, CDMO et FDF.[Voir le profil CDMO]
HIPRA Biotech Services :Capacités internes de bout en bout du développement de la lignée cellulaire à la fabrication commerciale.[Voir le profil CDMO]
Hbm Pharma : Manufacturing and packaging services for sterile pharmaceutical products and solid oral dosage forms. [Voir le profil CDMO]
BAG Health Care GmbH : Parenteral fill & finish provider for vials in small to mid-sized batches. [Voir le profil CDMO]
Vaccins CZ :Installation de fabrication à l'échelle commerciale.[Voir le profil CDMO]
Green Phoenix Labs GmbH :Fabrication GMP et libération de lots QP pour les thérapies cellulaires et tissulaires.[Voir le profil CDMO]
LABORATORIO REIG JOFRE SA : State-of-the-art facilities for the development and manufacturing of betalactam antibiotics (FDF). [Voir le profil CDMO]
Grifols International :Solutions de fabrication stériles pour petites molécules en sachets et flacons souples.[Voir le profil CDMO]
Adragos Pharma: Aseptic fill & finish manufacturing of lyophilized or liquid sterile (bio)pharmaceutical drug products. [Voir le profil CDMO]
Seda Pharma Development Services Ltd :Spécialisé dans le développement pharmaceutique intégré et la pharmacologie clinique.[Voir le profil CDMO]
STE PRASFARMA : CMO/CDMO specializing in cytostatics and high-potency products. [Voir le profil CDMO]
Sichuan Huiyu Pharmaceuticals :Spécialisé dans les services CMO/CDMO pour les API et les injectables complexes, y compriscartridge manufacturing.[Voir le profil CDMO]
Cenexi Injectables manufacturing. [Voir le profil CDMO]
ASCIL Biopharm : A GMP facility fully equipped for R&D and pharmaceutical development. Includes laboratories and a pilot plant for technical and clinical batches of sterile products. [Voir le profil CDMO]
White Raven:Site de remplissage et de finition dédié à la formulation BPF et au remplissage aseptique des injectables liquides stériles, y compris la fabrication de cartouches.[Voir le profil CDMO]
Solutions pharmaceutiques Ascendia : GMP-certified CDMO providing advanced sterile and non-sterile pharmaceutical manufacturing, formulation development, and analytical testing services. [Voir le profil CDMO]
Aenova Group:Centre de compétence spécialisé dans les formes posologiques solides conventionnelles et les services cliniques, ainsi que les produits pharmaceutiques semi-solides et liquides.[Voir le profil CDMO]
Lifecore Injectables CDMO :Fabrication clinique et commerciale de produits médicamenteux injectables stériles.[Voir le profil CDMO]

Related Information

Let MAI CDMO Help You Find the Right Cartridge Filling CDMO Partner

At MAI CDMO, we connect pharma and biotech companies with top-tier cartouche remplissant les sociétés CDMOoffrant un service completfabrication de cartouches injectables solutions. Whether you’re developing a new combination product or scaling an approved injectable, our network ensures you find the right partner to meet your technical and commercial needs.

Looking to outsource sterile cartridge production? Contact us today and let’s match you with the ideal CDMO.

Entreprises CDMO de remplissage de cartouches|Services de fabrication de cartouches injectables

Vos partenaires de confiance pour la fabrication et le développement de cartouches injectables

Filters

FDF / DRUG PRODUCTS manufacturing site

COSMETICS manufacturing site

FDF / DRUG PRODUCTS manufacturing site

More facilities on the network

Filters

FDF / DRUG PRODUCTS manufacturing site

COSMETICS manufacturing site

FDF / DRUG PRODUCTS manufacturing site

More facilities on the network

Comment choisir les sociétés CDMO de remplissage de cartouches

Principaux services offerts par les partenaires de fabrication de cartouches injectables

Advantages of Partnering with Cartridge Filling CDMO Companies

Sociétés CDMO de remplissage de cartouches

Related Information

Let MAI CDMO Help You Find the Right Cartridge Filling CDMO Partner

Entreprises CDMO de remplissage de cartouches|
Services de fabrication de cartouches injectables